Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum: Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice.

Genes & development·2026
Same author

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Nature·2026
Same author

A CDCA2-MYC positive feedback loop controls cancer cells survival.

Open biology·2026
Same author

MYC at the tumor-immune interface: mechanisms of immune escape and immunotherapy resistance.

Frontiers in immunology·2026
Same author

The leading role of MYC in DNA damage response: exploring opportunities for therapeutic inhibition.

Frontiers in cell and developmental biology·2026
Same author

A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K

Tamoxifen administration to mice.

Jonathan Whitfield1, Trevor Littlewood2, Laura Soucek1

  • 1Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain; Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain;

Cold Spring Harbor Protocols
|March 4, 2015
PubMed
Summary

Researchers explored tamoxifen delivery methods in mice for controlling fused protein activity. Intraperitoneal injection offers better dose control than oral gavage for tamoxifen-based systems.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.1K
Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
07:05

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

57.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.7K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.1K
Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
07:05

Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad

Published on: January 20, 2019

57.5K

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Pharmacology

Background:

  • Fusion proteins with hormone-binding domains (HBDs) offer inducible control over protein activity.
  • The murine estrogen receptor (ER) fusion system utilizes a mutant ER (ER(TAM)) with low estrogen affinity but high sensitivity to 4-hydroxytamoxifen (4-OHT).
  • Tamoxifen is a precursor to 4-OHT, requiring hepatic conversion, making it a cost-effective alternative for in vivo studies.

Purpose of the Study:

  • To provide an overview of tamoxifen administration methods in mice for ER fusion systems.
  • To compare the efficacy and control offered by different tamoxifen delivery routes.

Main Methods:

  • Review of established methods for tamoxifen delivery in murine models.
  • Comparison of intraperitoneal injection and oral gavage for tamoxifen administration.
  • Consideration of direct 4-OHT administration for specific experimental designs.

Main Results:

  • Intraperitoneal injection is the preferred method for precise tamoxifen dose control.
  • Oral gavage is a viable alternative delivery route.
  • Direct 4-OHT administration bypasses hepatic metabolism for immediate effects.

Conclusions:

  • Tamoxifen delivery methods significantly impact the control and timing of ER fusion protein activation in mice.
  • Choice of delivery route (intraperitoneal injection vs. oral gavage) depends on experimental requirements for dose accuracy.
  • Direct 4-OHT use is suitable for studies requiring rapid, metabolism-independent induction.